12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga·04/07/2026 21:05:49

Listen to the news

Gainers

Quince Therapeutics (NASDAQ:QNCX) shares increased by 35.0% to $0.22 during Tuesday's after-market session. The company's market cap stands at $4.8 million.
Decoy Therapeutics (NASDAQ:DCOY) stock rose 25.64% to $7.3. The company's market cap stands at $3.1 million.
Iridex (NASDAQ:IRIX) shares increased by 22.33% to $1.26. The market value of their outstanding shares is at $17.1 million.
NewcelX (NASDAQ:NCEL) shares rose 13.94% to $2.37. The company's market cap stands at $9.7 million.
Galectin Therapeutics (NASDAQ:GALT) stock rose 9.36% to $2.4. The company's market cap stands at $168.5 million.
Alvotech (NASDAQ:ALVO) shares increased by 7.96% to $3.66. The company's market cap stands at $1.1 billion.

Losers

Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares declined by 17.2% to $0.5 during Tuesday's after-market session. The company's market cap stands at $2.9 million.
Processa Pharma (NASDAQ:PCSA) shares fell 7.15% to $2.67. The company's market cap stands at $7.4 million.
Impact BioMedical (AMEX:IBO) shares fell 6.58% to $0.63. The market value of their outstanding shares is at $69.0 million.
Cyclerion Therapeutics (NASDAQ:CYCN) shares decreased by 6.33% to $3.26. The company's market cap stands at $15.7 million.
Capricor Therapeutics (NASDAQ:CAPR) shares fell 6.07% to $30.03. The market value of their outstanding shares is at $1.8 billion.
Artelo Biosciences (NASDAQ:ARTL) stock fell 6.04% to $6.85. The market value of their outstanding shares is at $4.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English